COMPARATIVE ANALYSIS OF THE USE OF IMMUNOGLOBULIN REPLACEMENT THERAPY IN PATIENTS WITH ACUTE LEUKEMIA.

EHA Library, Olga Gerasimovich, 422054

SMUDGE CELLS IN COVID-19 PATIENTS

EHA Library, Athanasia Agorasti, 422055

TUBERCULOSIS-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INSIGHTS FROM A GLOBAL SYSTEMATIC REVIEW

EHA Library, shaya alimoghadam, 422056

ANALYSIS OF POTENTIAL CATEGORIES AND INFLUENCING FACTORS OF COMPLIANCE WITH STANDARD PREVENTIVE BEHAVIOR AMONG HEMATOLOGY NURSES IN CHONGQING

EHA Library, Xin Du, 422057

THE CORRELATION OF CD4/CD8 RATIO WITH T LYMPHOCYTE FUNCTIONS IN LONG-TERM VIRALLY SUPPRESSED PATIENTS WITH HIV

EHA Library, Qing Xiao, 422058

EXPLORATION OF THE PRACTICAL DOSE OF LIPOSOMAL AMPHOTERICIN B (L-AMB) IN CHINESE IFD PATIENTS WITH HEMATOLOGIC MALIGNANCIES

EHA Library, JUN ZHU, 422059

EMERGENCE OF BLOODSTREAM INFECTION CARBAPENEM RESISTANT IN PATIENTS HOSPITALIZED: EXPERIENCE  IN  A SINGLE HEMATOLOGY UNIT

EHA Library, Caterina BUQUICCHIO, 422060

NAVIGATING THE THERAPEUTIC LANDSCAPE: A CASE OF MULTICENTRIC CASTLEMAN DISEASE IN THE CONTEXT OF KAPOSI SARCOMA-ASSOCIATED HERPESVIRUS 8

EHA Library, Pedro Lupi, 422061

THE SAFETY AND EFFICACY OF LETERMOVIR IN THE PROPHYLAXIS OF CMV DISEASE OR REACTIVATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, jinyan Xiao, 422062

ASSESSMENT OF INFECTION BREAKTHROUGH GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) IN PATIENTS WITH MATURE B-CELL LYMPHOMA PATIENTS UNDERWENT CHEMOTHERAPY

EHA Library, Supat Chamnanchanunt, 422063

STRATEGY FOR OVERCOMING ANTIBIOTIC RESISTANCE OF CONDITIONALLY PATHOGENIC MICROORGANISMS

EHA Library, Alla Rybalska, 422064

INHIBITORS OF THE NON-STRUCTURAL PROTEIN 5A: FROM THE CONTROL OF HEPATITIS C TO THAT OF MALARIA?

EHA Library, Yosra BEN OTHMENE, 422065

BLOOD TRANSFUSION IN CARDIOPULMONARY BYPASS SURGERY, A SERVICE EVALUATION

EHA Library, Silvia Lovato, 422066

BLOOD TRANSFUSION REQUIREMENT FOR COVID-19 PATIENTS WITH PNEUMONIA VERSUS PATIENTS WITH NON-COVID PATHOLOGY IN ICU OF A TERTIARY HOSPITAL IN NORTHERN GREECE.

EHA Library, Stamatia Theodoridou, 422067

CARDIAC SURGERY: WHICH PROCEDURES ARE USING MORE BLOOD PRODUCTS?

EHA Library, Silvia Lovato, 422068

IMPLEMENTATION OF AN OPTIMAL USE PROTOCOL (PBM) FOR PLATELET CONCENTRATE. PRELIMINARY RESULTS.

EHA Library, José María Domingo-Morera, 422069

TRANSFUSION MANAGEMENT FOR ALLOGENEIC BONE MARROW TRANSPLANTATION IN MULTIRACIAL PATIENTS.

EHA Library, Meri Abovyan, 422070

WHICH FACTORS CAN INFLUENCE HEMOGLOBIN CONTENT IN RBC UNITS?

EHA Library, Asma Boughanmi, 422071

RED BLOOD CELLS INTENDED FOR TRANSFUSION: A CLINICAL AUDIT ON HEMATOLOGICAL QUALITY CRITERIA

EHA Library, Asma Boughanmi, 422072

ASSOCIATION OF FEBRILE NEUTROPENIA EPISODES AND BLOOD PRODUCT TRANSFUSION IN CHILDREN WITH ACUTE LEUKEMIA

EHA Library, Hale Ören, 422073

EVALUATION OF THE TRANSFUSION OF RED BLOOD CELLS IN THE EMERGENCY DEPARTMENT OF A REGIONAL HOSPITAL

EHA Library, MARIA TERESA ORDUNA ARNAL, 422074

ASSESSMENT OF THE KNOWLEGDE OF INTERNS AND RESIDENTS IN TRANSFUSION, A MONOCENTRIC TUNISIAN STUDY

EHA Library, Ikbel Ghachem, 422075

A EUROPEAN RETROSPECTIVE STUDY TO DESCRIBE REAL-WORLD OUTCOMES, TREATMENT PATTERNS AND RESOURCE USE IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) TREATED WITH AVATROMBOPAG: INTERIM RESULTS

EHA Library, Francesco Zaja, 422076

IMMATURE PLATELET FRACTION AND OTHER HEMATOLOGICAL PARAMETERS IN THE DIFFERENTIAL DIAGNOSIS OF THROMBOCYTOPENIA IN PEDIATRIC PATIENTS

EHA Library, Joana Azevedo, 422078

A NOVEL VARIANT OF THE CYCS GENE IN A FAMILY WITH THROMBOCYTOPENIA ALTERS TNFA SIGNALING AND APOPTOSIS OF MEGAKARYOCYTES

EHA Library, Vasiliki Pappa, 422079

AVATROMBOPAG IN IMMUNE THROMBOCYTOPENIA (ITP): A REAL LIFE SINGLE CENTRE EXPERIENCE IN 20 CONSECUTIVE PATIENTS

EHA Library, María Menor Gómez, 422080

EFFICACY AND SAFETY OF HETROMBOPAG IN INCREASING PLATELET COUNTS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING HEPATECTOMY: A RANDOMIZED, PLACEBO-CONTROLLED STUDY

EHA Library, Wang Lu, 422081

EFFICACY OF HETROMBOPAG IN TREATMENT OF CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA IN ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Meng Li, 422082

A SINGLE-ARM, PROSPECTIVE, SINGLE-CENTER CLINICAL STUDY ON THE USE OF HETROMBOPAG FOR THE PREVENTION OF CONSOLIDATION CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA IN ACUTE LEUKEMIA

EHA Library, dingjun Zhuo, 422083

THE PLATELET VARIABILITY INDEX (PVI) SCORE AS A MEASURE OF THE EFFECT OF TREATMENTS FOR IMMUNE THROMBOCYTOPENIA (ITP)

EHA Library, Donald Arnold, 422084

EXPLORATORY TRIAL OF HETROMBOPAG IN THE TREATMENT OF THROMBOCYTOPENIA INDUCED BY CHEMORADIOTHERAPY IN PATIENTS WITH GYNECOLOGICAL MALIGNANCIES

EHA Library, jinrong wu, 422085

COMBINATION OF ALL-TRANS RETINOIC ACID RESUMES THE SUSTAINED RESPONSE OF TPO-RA IN ITP

EHA Library, Jieyu Ye, 422086

RETROSPECTIVE STUDY FROM VARIOUS CENTERS ON THE EXPERIENCE WITH AVATROMBOPAG IN THE NORTHWEST OF SPAIN

EHA Library, Ana Lorenzo Vizcaya, 422087

EFFICACY AND SAFETY OF FOSTAMATINIB FOR IMMUNE THROMBOCYTOPENIA IN CLINICAL PRACTICE IN SPAIN: RESULTS OF FOSTAMES, OUR NATIONAL FOSTAMATINIB REGISTRY

EHA Library, Tomás José González-López, 422089

AVATROMBOPAG PLUS FOSTAMATINIB COMBINATION EFFICACY AND SAFETY IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA

EHA Library, Maria-Eva Mingot-Castellano, 422090

ACUTE EVENTS OF CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA WITH AND WITHOUT PROPHYLAXIS THERAPIES IN A FRENCH PATIENT POPULATION

EHA Library, Paul Coppo, 422091

CLINICAL FEATURES OF PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) PATIENTS SUBSEQUENTLY DEVELOPING SYSTEMIC LUPUS ERYTHEMATOSUS: REAL WORLD DATA FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY

EHA Library, Charalampos Pontikoglou, 422092

OBINUTUZUMAB TREATMENT IN IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA

EHA Library, Júlia Weisinger, 422093

ELTROMBOPAG INHIBITS THE PROLIFERATION OF CD8 T CELLS THROUGH AN IRON CHELATION MANNER

EHA Library, Michelle Tan, 422094

IMPACT OF THROMBOPOIETIN RECEPTOR AGONISTS AND ADHERENCE TO INSTRUCTIONS FOR TREATMENT OF PRIMARY CHRONIC IMMUNE THROMBOCYTOPENIA: INTERIM RESULTS OF A REAL-WORLD CROSS-SECTIONAL INTERNATIONAL SURVEY

EHA Library, Srikanth Nagalla, 422095

EFFICACY AND SAFETY OF HETROMBOPAG FOR SECONDARY PREVENTION OF CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA IN PATIENTS WITH GYNECOLOGICAL MALIGNANCIES: A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM STUDY

EHA Library, miaofang wu, 422096

PRECISION QUANTITATIVE ANALYSIS OF PLATELET SIZE COMBINED WITH NGS IN THE ACTIVE SCREENING OF INHERITED MACROTHROMBOCYTOPENIA—A SINGLE-CENTER PROSPECTIVE STUDY

EHA Library, Abdul Rehman Arif, 422097

RESPONSE OF CD19+ CD38+ B-CELLS TO CORTICOSTEROID THERAPY IN IMMUNE THROMBOCYTOPENIA PATIENTS AS A PREDICTOR TO DISEASE OUTCOME

EHA Library, Noreen Elbayoumi, 422098

ADVANCEMENTS IN LIPID BIOMARKER ASSESSMENT: LC-MS/MS AND DRIED BLOOD SPOT SAMPLES IN GAUCHER PATIENTS, A HEMATOLOGIC DISEASE

EHA Library, Isidro Arévalo-Vargas, 422099

HEAVY MENSTRUAL BLEEDING AS A PREDICTOR FOR HIGH-RISK BLEEDING IN IMMUNE THROMBOCYTOPENIA (ITP): DATA FROM THE PLATELET DISORDER SUPPORT ASSOCIATION’S ITP NATURAL HISTORY STUDY REGISTRY

EHA Library, Jennifer DiRaimo , 422100

COVID-19 AND AUTOIMMUNE CYTOPENIASCOVID-19 AND AUTOIMMUNE CYTOPENIAS

EHA Library, Bohdana Kuiavovych, 422101

REFRACTORINESS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) IN THE AGE OF NEW TARGETED DRUGS: STILL A CLINICAL UNRESOLVED ISSUE

EHA Library, Monica Carpenedo, 422102

INITIATIVES OF THE EAHAD GLANZMANN WORKING GROUP

EHA Library, Roger E.G. Schutgens, 422103

THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RAS): A PROMISING THERAPY FOR CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT)

EHA Library, Ludovica Fucci, 422104

DISCLOSING IMMUNE THROMBOCYTOPENIA: A RETROSPECTIVE COHORT ANALYSIS IN CALI, COLOMBIA (2016-2021)

EHA Library, Monica Fernandes Pineda, 422105

EPTIFIBATIDE INDUCED THROMBOCYTOPENIA IN ACUTE CORONARY SYNDROME: A RETROSPECTIVE DATA REVIEW

EHA Library, Shehab Fareed Abdelgabber, 422106

A PHASE 1B STUDY TO EVALUATE THE SAFETY AND PRELIMINARY EFFICACY OF SOVLEPLENIB, A SYK INHIBITOR, IN ADULT SUBJECTS WITH IMMUNE THROMBOCYTOPENIA

EHA Library, Waleed Ghanima, 422107

EFFECTS OF ORAL BRUTON TYROSINE KINASE INHIBITOR RILZABRUTINIB ON THE PLATELET VARIABILITY INDEX SCORE IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: PHASE 2 STUDY

EHA Library, Donald Arnold, 422108

EPIDEMIOLOGY, TREATMENT PATTERNS AND QUALITY OF LIFE IN PATIENTS WITH NEWLY DIAGNOSED ADULT IMMUNE THROMBOCYTOPENIA (ITP): RESULTS FROM THE PROSPECTIVE MULTICENTER GERMAN ITP REGISTRY (D.ITP)

EHA Library, Julia-Annabell Georgi, 422109

REAL-WORLD EXPERIENCE WITH FOSTAMATINIB IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: RESULTS OF AN OBSERVATIONAL STUDY (FORTE)

EHA Library, Drew Provan, 422110

THERAPY OF IMMUNE THROMBOCYTOPENIA WITH THROMBOPOIETIN RECEPTOR AGONISTS IN THE SECOND AND SUBSEQUENT LINES.

EHA Library, Maria Pankrashkina, 422111

MANAGING CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) WITH ELTROMBOPAG; A RETROSPECTIVE REAL-WORLD ANALYSIS

EHA Library, Mehmet Baysal, 422112

REAL WORLD DATA ON THROMBOTIC THROMBOCYTOPENIC PURPURA IN CROATIA FROM THE WORKING GROUP FOR BENIGN HEMATOLOGICAL DISEASES OF THE KROHEM

EHA Library, Drazen Pulanic, 422113

OUTCOMES OF COMBINATION THERAPY FOR PATIENTS WITH CHRONIC REFRACTORY ITP: INSIGHTS FROM A SINGLE-CENTRE EXPERIENCE

EHA Library, Lucy Kamuriwo, 422114

THROMBOCYTOPENIA IN HIV INFECTION

EHA Library, Chingiz Mabudzada, 422115

CYCLIC THROMBOCYTOPENIA: A CASE SERIES FROM MAYO CLINIC

EHA Library, Nadia Toumeh, 422116

CURRENT APPROACHES TO THE TREATMENT OF ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA: A COMPREHENSIVE REVIEW OF THERAPEUTIC STRATEGIES AND CONSIDERATIONS

EHA Library, Moazzam Shahzad, 422117

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA TREATED WITH AVATROMBOPAG IN THE UNITED STATES: REAL-AVA 2.0 INTERIM ANALYSIS RESULTS

EHA Library, Scott Kolodny, 422118

ROLE OF PLATELET TO LYMPHOCYTE RATIO (PLR) AS A PROGNOSTIC FACTOR IN IMMUNE THROMBOCYTOPENIA (ITP)

EHA Library, Claudia Pia Schifone, 422119

EXPRESSION OF BECLIN-1 AUTOPHAGY PROTEIN IN ITP PATIENTS

EHA Library, Fady Hennawy, 422120

ANTI-PHOPHATIDYL SERINE AND ANTI-PROTHROMBIN ANTIBODIES (APS/PT) INIMMUNE THROMBOCYTOPENIA: SPACE FOR A MISDIAGNOSED ANDUNDERSTIMATED FORM OF SECONDARY ITP?

EHA Library, Sofia Camerlo, 422121

COMPREHENSIVE CHARACTERIZATION OF HEMATOLOGICAL ALTERATIONS IN FAMILIAL SITOSTEROLEMIA

EHA Library, Miguel Oliveira, 422122

PREDICTION OF STEROID RESPONSE IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA BY EVALUATING CD20+ B CELLS IN THE BONE MARROW

EHA Library, Yosuke DOMON, 422123

DOES ADMINISTRATION OF INTRAVENOUS IMMUNOGLOBULIN IN COMBINATION WITH RITUXIMAB REDUCE ITS RESPONSE IN IMMUNE THROMBOCYTOPENIA?

EHA Library, Sylvain Audia, 422124

CHARACTERISTICS OF PATIENTS WITH CYCLIC THROMBOCYTOPENIA: AN INTERNATIONAL REGISTRY STUDY

EHA Library, Lisbeth Eischer, 422125

TREATMENT OF CRITICAL BLEEDS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW

EHA Library, Saifur Rahman Chowdhury, 422126

PREDICTION OF IMMUNE THROMBOCYTOPENIA PROGRESSIONBASED ON GLYCOCALICIN TEST DATA

EHA Library, Moldir Beshimbayeva, 422127

PHASE 4 STUDY RESULTS EVALUATING THE SAFETY, EFFICACY, AND TREATMENT SATISFACTION IN CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM

EHA Library, Scott Kolodny, 422128

SIALIC ACID LOSS IN PLATELETS: IMPLICATIONS IN PEDIATRIC PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA

EHA Library, Yessenia Lizbeth Molina Cabrera, 422129

CD8+CD25+ TREGS AS A PREDICTOR FOR GLUCOCORTICOID SENSITIVITY IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA

EHA Library, Sara El-sayed, 422131

EVANS SYNDROME IN CROATIA – DATA FROM THE WORKING GROUP FOR BENIGN HEMATOLOGICAL DISEASES OF THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGICAL DISEASES KROHEM

EHA Library, Zdravko Mitrovic, 422132

A MULTI-COHORT STUDY ON THE HEALTHCARE RESOURCE UTILIZATION OF PATIENTS WITH CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA

EHA Library, Paul Coppo, 422133

TREATMENT OUTCOMES OF TPO-RECEPTOR AGONISTS IN PATIENTS WITH STEROID-REFRACTORY IMMUNE THROMBOCYTOPENIA; CONDITIONS FOR DISCONTINUATION WITH SUSTAINED PLATELET RESPONSE

EHA Library, JAE HO YOON, 422134

SPLEEN MICROBIOTA DYSBIOSIS PLAY A ROLE IN RESPONSE TO SPLENECTOMY IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: A PROSPECTIVE COHORT STUDY

EHA Library, Jia Chen, 422135

FUNCTIONAL CHARACTERIZATION OF A NANOBODY BASED GPVI SPECIFIC PLATELET AGONIST

EHA Library, Minka Zivkovic, 422136

BASIC CHARACTERISTICS OF ADULT PATIENTS WITH PREVIOUSLY TREATED IMMUNE THROMBOCYTOPENIA ENROLLED IN LUNA 3 PHASE 3 PLACEBO-CONTROLLED STUDY OF RILZABRUTINIB, AN ORAL BRUTON TYROSINE KINASE INHIBITOR

EHA Library, David Kuter, 422137

REFRACTORY IMMUNE THROMBOCYTOPENIC PURPURA IN PREGNANCY: DISTRICT GENERAL HOSPITAL EXPERIENCE IN MANAGING CLINICAL AND BIO-PSYCHO-SOCIAL COMPLEXITIES RELATED TO THROMBOPOIETIN RECEPTOR AGONISTS

EHA Library, Diana Mihalca, 422138

LONG-TERM SAFETY OUTCOMES OF ELIGLUSTAT IN PATIENTS WITH GAUCHER DISEASE: PROSPECTIVE, MULTICENTER, OBSERVATIONAL, POST AUTHORIZATION SAFETY SUB-REGISTRY STUDY

EHA Library, Pilar Giraldo, 422139

STEROIDS VS ELTROMBOPAG FOR FIRST AND SECOND-LINE TREATMENT OF ADULT IMMUNE THROMBOCYTOPENIA

EHA Library, Carlos Martínez Murillo, 422140

TREATMENTS FOR IMMUNE THROMBOCYTOPENIA (ITP) PLACE A BURDEN ON PATIENTS AND IMPACT QUALITY OF LIFE (QOL): INSIGHTS FROM A SOCIAL MEDIA LISTENING EXERCISE

EHA Library, Caroline Kruse, 422142

THROMBOCYTOPENIA IN PREGNANCY : A DESCRIPTIVE STUDY AND MANAGEMENT OF GESTATIONAL THROMBOCYTOPENIA AND IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

EHA Library, Ines Ben Rekaya, 422143

SELECTION AND EFFICACY OF DIFFERENT TREATMENTS FOR ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: A CHINESE MONOCENTRIC RETROSPECTIVE STUDY

EHA Library, JIAN HUANG, 422144

THE ALTERNATIVE SPLICING OF LCK IN TREG INDUCTION IN IMMUNE THROMBOCYTOPENIA

EHA Library, Shaoqiu Leng, 422145

TREATMENT AND COMPLICATIONS OF PORTAL VEIN THROMBOSIS: HOW, HOW MUCH, AND FOR WHOM?

EHA Library, Mónica Fernández Pérez, 422146

ASSESSMENT OF THROMBIN GENERATION TEST USING ST-GENESIA® IN CARRIERS OF PROTHROMBIN G20210A MUTATION

EHA Library, Carlos Aguilar, 422147

GENETIC ASSOCIATION OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI:RS7586970 VARIANT) WITH CIRCULATING TISSUE FACTOR PATHWAY INHIBITOR LEVELS AND ISCHEMIC CORONARY ARTERY DISEASE

EHA Library, Doha Abdelhamid, 422148

APPROACH TO THE TREATMENT OF SUPERFICIAL THROMBOPHLEBITIS IN PREGNANCY – DATA FROM A PHYSICIAN SURVEY

EHA Library, Sajida Kazi, 422149

CLINICAL CHARACTERISTICS AND OUTCOMES OF YOUNG PATIENTS WITH THROMBOTIC MICROANGIOPATHY AT AIN-SHAMS UNIVERSITY CHILDREN’S HOSPITAL

EHA Library, Sara Makkeyah, 422150

PECTORAL MUSCLE LOSS  IS ASSOCIATED WITH ELEVATED FIBRINOLYTIC SYSTEM COMPONENTS IN COVID-19

EHA Library, Taner Tan, 422151

PREVALENCE AND VENOUS THROMBOTIC RISK OF ARG67STOP POLYMORPHISM IN THE PROTEIN Z-DEPENDENT PROTEASE INHIBITOR

EHA Library, Nuria Bermejo-Vega, 422152

VON WILLEBRAND FACTOR (VWF) AS A BIOMARKER OF SEVERITY IN INFECTION: THE CASE OF THE COVID-19 DISEASE

EHA Library, Panagiota Tsiatsiou, 422153

PHLEGMASIA CERULEA DOLENS IN A PATIENT WITH MAY THURNER SYNDROME – A CASE REPORT

EHA Library, Joana Ribeiro, 422154

USAGE PATTERN OF ANTICOAGULANTS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES RECEIVING ANTICANCER THERAPIES IN EU4 + UK.

EHA Library, Magdalena Ruiz, 422155

ATYPICAL PRESENTATIONS OF PEDIATRIC ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

EHA Library, Assaf Barg, 422156

A COMPARATIVE ANALYSIS OF CONCENTRATIONS OF DIRECT ORAL ANTICOAGULANTS USING TWO ANTI-XA REAGENTS: DOAC LEVELS IN PATIENTS PLASMA

EHA Library, Sun Hack Lee, 422157